Erytech Pharma is focused on developing immune modulating therapies using its ERYCAPS platform, which encapsulates drugs into red blood cells
Erytech Pharma is focused on developing immune modulating therapies using its ERYCAPS platform, which encapsulates drugs into red blood cells. The company is exploring applications in cancer immunotherapies and enzyme therapies.